Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peritoneal Neoplasms | 35 | 2024 | 715 | 5.800 |
Why?
|
Hyperthermia, Induced | 27 | 2024 | 417 | 4.710 |
Why?
|
Appendiceal Neoplasms | 13 | 2022 | 155 | 3.280 |
Why?
|
Carcinoma, Hepatocellular | 19 | 2024 | 2336 | 3.000 |
Why?
|
Liver Neoplasms | 24 | 2024 | 4365 | 2.890 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 14 | 2022 | 94 | 2.470 |
Why?
|
Hepatectomy | 12 | 2020 | 588 | 1.850 |
Why?
|
Gallbladder Neoplasms | 7 | 2024 | 191 | 1.500 |
Why?
|
Adenocarcinoma, Mucinous | 7 | 2020 | 526 | 1.340 |
Why?
|
Mitomycin | 3 | 2017 | 262 | 1.150 |
Why?
|
Cholecystectomy | 3 | 2024 | 409 | 1.010 |
Why?
|
Pseudomyxoma Peritonei | 3 | 2019 | 21 | 0.960 |
Why?
|
Colorectal Neoplasms | 14 | 2024 | 6971 | 0.960 |
Why?
|
Hepatitis B, Chronic | 4 | 2021 | 413 | 0.960 |
Why?
|
Emigrants and Immigrants | 3 | 2021 | 549 | 0.920 |
Why?
|
Combined Modality Therapy | 29 | 2024 | 8562 | 0.880 |
Why?
|
Stomach Neoplasms | 7 | 2024 | 1484 | 0.790 |
Why?
|
Pancreatic Neoplasms | 12 | 2023 | 5443 | 0.770 |
Why?
|
Adenocarcinoma | 13 | 2023 | 6406 | 0.760 |
Why?
|
Gastrectomy | 3 | 2024 | 696 | 0.760 |
Why?
|
Adenocarcinoma, Papillary | 2 | 2022 | 86 | 0.740 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2019 | 594 | 0.730 |
Why?
|
Hepatitis B | 3 | 2021 | 708 | 0.710 |
Why?
|
Laparoscopy | 9 | 2024 | 2056 | 0.700 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2024 | 617 | 0.610 |
Why?
|
Survival Rate | 27 | 2024 | 12870 | 0.580 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9433 | 0.570 |
Why?
|
Neoplasm Staging | 16 | 2024 | 11254 | 0.560 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 196 | 0.560 |
Why?
|
Leukopenia | 1 | 2017 | 212 | 0.560 |
Why?
|
Diaphragm | 2 | 2019 | 359 | 0.560 |
Why?
|
Liver Cirrhosis | 5 | 2024 | 1959 | 0.550 |
Why?
|
Prognosis | 30 | 2024 | 30022 | 0.540 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2023 | 1755 | 0.530 |
Why?
|
Ablation Techniques | 2 | 2016 | 255 | 0.520 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2017 | 677 | 0.510 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2024 | 11854 | 0.500 |
Why?
|
Cholangiocarcinoma | 3 | 2023 | 562 | 0.490 |
Why?
|
Bile Duct Neoplasms | 3 | 2023 | 616 | 0.490 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2016 | 128 | 0.480 |
Why?
|
Retrospective Studies | 51 | 2024 | 81801 | 0.470 |
Why?
|
New York City | 7 | 2021 | 737 | 0.460 |
Why?
|
Lymphocytes | 2 | 2021 | 2611 | 0.450 |
Why?
|
Pain, Postoperative | 1 | 2024 | 1765 | 0.450 |
Why?
|
Niacinamide | 1 | 2016 | 418 | 0.440 |
Why?
|
Laparoscopes | 1 | 2012 | 37 | 0.420 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 530 | 0.410 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2012 | 47 | 0.410 |
Why?
|
Cautery | 1 | 2012 | 73 | 0.400 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 127 | 0.400 |
Why?
|
Neutropenia | 1 | 2017 | 893 | 0.400 |
Why?
|
Middle Aged | 59 | 2024 | 223491 | 0.390 |
Why?
|
Monocytes | 1 | 2021 | 2595 | 0.390 |
Why?
|
Tumor Burden | 2 | 2021 | 1913 | 0.380 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3413 | 0.370 |
Why?
|
Social Class | 2 | 2018 | 2009 | 0.360 |
Why?
|
Research Subjects | 1 | 2013 | 249 | 0.360 |
Why?
|
Carcinoma | 4 | 2019 | 2341 | 0.360 |
Why?
|
Hepatitis C | 1 | 2021 | 1593 | 0.360 |
Why?
|
Sutures | 1 | 2012 | 283 | 0.360 |
Why?
|
Cryoglobulinemia | 1 | 2010 | 84 | 0.340 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2010 | 20 | 0.340 |
Why?
|
Humans | 104 | 2024 | 768393 | 0.330 |
Why?
|
Aged | 46 | 2024 | 171562 | 0.330 |
Why?
|
Male | 64 | 2024 | 364902 | 0.330 |
Why?
|
Colectomy | 1 | 2014 | 699 | 0.330 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1813 | 0.320 |
Why?
|
Pancreatectomy | 4 | 2023 | 824 | 0.320 |
Why?
|
Lymph Node Excision | 4 | 2024 | 1274 | 0.310 |
Why?
|
Carcinoma, Signet Ring Cell | 2 | 2019 | 81 | 0.300 |
Why?
|
Female | 66 | 2024 | 397089 | 0.300 |
Why?
|
Analgesics, Opioid | 1 | 2024 | 3836 | 0.300 |
Why?
|
Residence Characteristics | 1 | 2018 | 2122 | 0.290 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7453 | 0.270 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.270 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2007 | 87 | 0.270 |
Why?
|
Guideline Adherence | 1 | 2017 | 2240 | 0.270 |
Why?
|
Program Development | 1 | 2012 | 1298 | 0.270 |
Why?
|
Vasculitis | 1 | 2010 | 524 | 0.260 |
Why?
|
Follow-Up Studies | 16 | 2024 | 39407 | 0.260 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6541 | 0.260 |
Why?
|
Carcinoma in Situ | 2 | 2022 | 789 | 0.250 |
Why?
|
Adult | 39 | 2024 | 223640 | 0.250 |
Why?
|
Health Status Disparities | 2 | 2014 | 1882 | 0.250 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2005 | 33 | 0.240 |
Why?
|
Rectal Prolapse | 1 | 2005 | 33 | 0.240 |
Why?
|
Incidental Findings | 1 | 2010 | 698 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3231 | 0.230 |
Why?
|
Pancreaticoduodenectomy | 4 | 2023 | 516 | 0.230 |
Why?
|
Aftercare | 2 | 2022 | 921 | 0.230 |
Why?
|
New York | 4 | 2022 | 884 | 0.230 |
Why?
|
Treatment Outcome | 18 | 2024 | 65379 | 0.230 |
Why?
|
Liver Transplantation | 1 | 2016 | 2400 | 0.220 |
Why?
|
Cefoxitin | 1 | 2023 | 35 | 0.220 |
Why?
|
Bandages | 1 | 2005 | 273 | 0.210 |
Why?
|
Students, Medical | 3 | 2013 | 1964 | 0.210 |
Why?
|
Overnutrition | 1 | 2022 | 25 | 0.210 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 419 | 0.210 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2021 | 3553 | 0.210 |
Why?
|
Hepatitis C, Chronic | 1 | 2010 | 1031 | 0.200 |
Why?
|
Laparotomy | 1 | 2024 | 459 | 0.200 |
Why?
|
Hernia, Inguinal | 1 | 2005 | 225 | 0.200 |
Why?
|
Education, Medical | 2 | 2013 | 1742 | 0.190 |
Why?
|
Hypophosphatemia | 1 | 2022 | 93 | 0.190 |
Why?
|
Digestive System Surgical Procedures | 2 | 2018 | 584 | 0.190 |
Why?
|
Calcinosis | 1 | 2010 | 1481 | 0.180 |
Why?
|
Neoplasm Invasiveness | 5 | 2020 | 3633 | 0.180 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5512 | 0.180 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2022 | 110 | 0.180 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2020 | 50 | 0.180 |
Why?
|
Colon | 3 | 2020 | 1805 | 0.180 |
Why?
|
Jaundice | 1 | 2020 | 95 | 0.170 |
Why?
|
Dehydration | 1 | 2022 | 216 | 0.170 |
Why?
|
Sepsis | 3 | 2023 | 2601 | 0.170 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 67 | 0.170 |
Why?
|
Aged, 80 and over | 16 | 2022 | 59686 | 0.170 |
Why?
|
Digestive System Neoplasms | 1 | 2020 | 83 | 0.170 |
Why?
|
Rectum | 1 | 2005 | 902 | 0.170 |
Why?
|
Survival Analysis | 4 | 2021 | 10117 | 0.170 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12092 | 0.170 |
Why?
|
Logistic Models | 4 | 2017 | 13323 | 0.160 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3438 | 0.160 |
Why?
|
Postoperative Complications | 10 | 2024 | 15881 | 0.160 |
Why?
|
Platelet Count | 2 | 2012 | 784 | 0.160 |
Why?
|
Vagina | 1 | 2005 | 845 | 0.160 |
Why?
|
Superinfection | 1 | 2019 | 63 | 0.160 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6856 | 0.160 |
Why?
|
Health Care Reform | 1 | 2008 | 1262 | 0.160 |
Why?
|
Carcinoembryonic Antigen | 1 | 2019 | 338 | 0.150 |
Why?
|
Ileum | 2 | 2014 | 558 | 0.150 |
Why?
|
Risk Factors | 9 | 2024 | 74962 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2021 | 1605 | 0.140 |
Why?
|
Mass Screening | 2 | 2021 | 5451 | 0.140 |
Why?
|
Malnutrition | 1 | 2023 | 631 | 0.140 |
Why?
|
CA-125 Antigen | 1 | 2019 | 281 | 0.140 |
Why?
|
Research Design | 1 | 2013 | 6210 | 0.140 |
Why?
|
Preventive Health Services | 1 | 2022 | 568 | 0.140 |
Why?
|
Digestive System Diseases | 1 | 2018 | 152 | 0.140 |
Why?
|
Proctocolectomy, Restorative | 2 | 2009 | 191 | 0.140 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13697 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 370 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1766 | 0.130 |
Why?
|
Neoplasms | 4 | 2023 | 22385 | 0.130 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1545 | 0.130 |
Why?
|
Wound Healing | 1 | 2007 | 2813 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2020 | 959 | 0.130 |
Why?
|
Lymphatic Metastasis | 4 | 2023 | 2925 | 0.130 |
Why?
|
Time Factors | 8 | 2019 | 40272 | 0.120 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 417 | 0.120 |
Why?
|
Insulinoma | 1 | 2015 | 122 | 0.120 |
Why?
|
Focus Groups | 2 | 2018 | 1453 | 0.120 |
Why?
|
Prospective Studies | 9 | 2024 | 54920 | 0.120 |
Why?
|
Hepacivirus | 1 | 2021 | 1342 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2952 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1241 | 0.110 |
Why?
|
Intestine, Large | 1 | 2013 | 69 | 0.110 |
Why?
|
Young Adult | 9 | 2019 | 60049 | 0.110 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2013 | 141 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2008 | 4339 | 0.100 |
Why?
|
Student Dropouts | 1 | 2012 | 27 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 658 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7861 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 811 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12558 | 0.100 |
Why?
|
Age Factors | 5 | 2019 | 18471 | 0.100 |
Why?
|
Risk Assessment | 7 | 2023 | 24318 | 0.100 |
Why?
|
Urogenital Neoplasms | 1 | 2013 | 133 | 0.100 |
Why?
|
Pancreas | 1 | 2019 | 1702 | 0.100 |
Why?
|
Needs Assessment | 2 | 2022 | 1142 | 0.100 |
Why?
|
Receptors, Peptide | 1 | 2013 | 280 | 0.100 |
Why?
|
Ethics Committees, Research | 1 | 2013 | 196 | 0.090 |
Why?
|
Endosonography | 1 | 2015 | 622 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1753 | 0.090 |
Why?
|
Neoadjuvant Therapy | 4 | 2023 | 2909 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2014 | 403 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1937 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 848 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2012 | 309 | 0.090 |
Why?
|
Patient Readmission | 2 | 2022 | 3312 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5375 | 0.090 |
Why?
|
Pneumonectomy | 1 | 2017 | 1158 | 0.080 |
Why?
|
Anastomotic Leak | 2 | 2022 | 171 | 0.080 |
Why?
|
International Normalized Ratio | 1 | 2011 | 382 | 0.080 |
Why?
|
Bilirubin | 1 | 2011 | 438 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2012 | 364 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1332 | 0.080 |
Why?
|
Capitalism | 1 | 2008 | 16 | 0.080 |
Why?
|
Serum Albumin | 1 | 2011 | 676 | 0.080 |
Why?
|
Propensity Score | 1 | 2016 | 1962 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 887 | 0.070 |
Why?
|
National Health Insurance, United States | 1 | 2008 | 100 | 0.070 |
Why?
|
Single-Payer System | 1 | 2008 | 35 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 105 | 0.070 |
Why?
|
Hospital Volunteers | 1 | 2007 | 5 | 0.070 |
Why?
|
Stomach Ulcer | 1 | 2007 | 120 | 0.070 |
Why?
|
Incidence | 3 | 2023 | 21544 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3236 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2015 | 1525 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 15872 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3107 | 0.070 |
Why?
|
Colitis, Ulcerative | 2 | 2009 | 1929 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2019 | 4936 | 0.070 |
Why?
|
Intestinal Neoplasms | 1 | 2009 | 316 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3939 | 0.070 |
Why?
|
Unemployment | 1 | 2008 | 210 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2012 | 1397 | 0.060 |
Why?
|
Hemostatic Techniques | 1 | 2007 | 116 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1248 | 0.060 |
Why?
|
Infusions, Parenteral | 2 | 2016 | 397 | 0.060 |
Why?
|
Patient Selection | 4 | 2021 | 4266 | 0.060 |
Why?
|
Rectovaginal Fistula | 1 | 2005 | 12 | 0.060 |
Why?
|
Tissue Adhesives | 1 | 2007 | 179 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3008 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 950 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1627 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4069 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3529 | 0.060 |
Why?
|
Anus Neoplasms | 1 | 2008 | 337 | 0.060 |
Why?
|
Body Weights and Measures | 1 | 2005 | 208 | 0.060 |
Why?
|
Reoperation | 1 | 2014 | 4341 | 0.060 |
Why?
|
Hemostatics | 1 | 2007 | 246 | 0.060 |
Why?
|
Ovarian Neoplasms | 3 | 2019 | 4907 | 0.060 |
Why?
|
Minority Groups | 1 | 2011 | 1215 | 0.060 |
Why?
|
Adolescent | 4 | 2017 | 89184 | 0.050 |
Why?
|
Piperacillin | 1 | 2023 | 37 | 0.050 |
Why?
|
Recurrence | 1 | 2016 | 8506 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8634 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2023 | 41 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16721 | 0.050 |
Why?
|
Medically Uninsured | 1 | 2008 | 841 | 0.050 |
Why?
|
Fundoplication | 1 | 2003 | 144 | 0.050 |
Why?
|
United States | 4 | 2018 | 73150 | 0.050 |
Why?
|
Pancreatic Fistula | 1 | 2023 | 149 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3048 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 8075 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 304 | 0.050 |
Why?
|
Prealbumin | 1 | 2023 | 259 | 0.050 |
Why?
|
Peritoneum | 1 | 2022 | 231 | 0.050 |
Why?
|
Clinical Competence | 2 | 2019 | 4848 | 0.050 |
Why?
|
Edema | 1 | 2005 | 766 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13646 | 0.040 |
Why?
|
Blood Transfusion | 2 | 2020 | 1309 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20765 | 0.040 |
Why?
|
Inflammation | 2 | 2022 | 10863 | 0.040 |
Why?
|
Rural Health Services | 1 | 2024 | 393 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 414 | 0.040 |
Why?
|
Common Bile Duct | 1 | 2020 | 106 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13020 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2022 | 685 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30228 | 0.040 |
Why?
|
Omentum | 1 | 2020 | 168 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3486 | 0.040 |
Why?
|
Liver | 3 | 2022 | 7574 | 0.040 |
Why?
|
Sex Factors | 2 | 2011 | 10654 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3112 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6350 | 0.040 |
Why?
|
Uganda | 1 | 2024 | 1351 | 0.040 |
Why?
|
Pleural Effusion, Malignant | 1 | 2020 | 108 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9682 | 0.040 |
Why?
|
Chest Tubes | 1 | 2019 | 153 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3922 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2007 | 829 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 765 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 775 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
International Cooperation | 1 | 2024 | 1438 | 0.040 |
Why?
|
Length of Stay | 3 | 2024 | 6519 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4941 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 232 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 406 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2013 | 22296 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15939 | 0.040 |
Why?
|
Child, Preschool | 3 | 2012 | 42650 | 0.030 |
Why?
|
Duodenum | 1 | 2020 | 495 | 0.030 |
Why?
|
Abscess | 1 | 2020 | 606 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1758 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1416 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26375 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1309 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 643 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9742 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11120 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2005 | 26411 | 0.030 |
Why?
|
General Surgery | 1 | 2007 | 1713 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 835 | 0.030 |
Why?
|
Stomach | 1 | 2019 | 703 | 0.030 |
Why?
|
Home Care Services | 1 | 2022 | 659 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9111 | 0.030 |
Why?
|
Developing Countries | 1 | 2007 | 2903 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17575 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2020 | 1176 | 0.030 |
Why?
|
Drainage | 1 | 2019 | 1184 | 0.030 |
Why?
|
Citrobacter rodentium | 1 | 2013 | 64 | 0.030 |
Why?
|
Lung Diseases | 1 | 2003 | 1925 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1367 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2014 | 253 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5705 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7463 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 408 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3712 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2012 | 146 | 0.020 |
Why?
|
Medicine, Chinese Traditional | 1 | 2012 | 75 | 0.020 |
Why?
|
Child | 3 | 2012 | 80891 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 2015 | 530 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5857 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3471 | 0.020 |
Why?
|
Enterobacteriaceae Infections | 1 | 2013 | 190 | 0.020 |
Why?
|
Hospitals, Private | 1 | 2011 | 67 | 0.020 |
Why?
|
Camptothecin | 1 | 2014 | 593 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3131 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2014 | 771 | 0.020 |
Why?
|
Hospitals, Public | 1 | 2011 | 205 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2013 | 391 | 0.020 |
Why?
|
New England | 1 | 2012 | 1058 | 0.020 |
Why?
|
Metagenome | 1 | 2013 | 465 | 0.020 |
Why?
|
Communication Barriers | 1 | 2012 | 419 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3476 | 0.020 |
Why?
|
Colonic Pouches | 1 | 2009 | 122 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3543 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6808 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1218 | 0.020 |
Why?
|
Internship and Residency | 1 | 2007 | 5949 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3801 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3858 | 0.020 |
Why?
|
Abdomen | 1 | 2012 | 1136 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 1262 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3827 | 0.020 |
Why?
|
China | 1 | 2012 | 2395 | 0.020 |
Why?
|
Schools, Medical | 1 | 2012 | 881 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2008 | 602 | 0.020 |
Why?
|
Educational Measurement | 1 | 2012 | 1256 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 993 | 0.020 |
Why?
|
Altruism | 1 | 2007 | 212 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 41795 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36849 | 0.010 |
Why?
|
Comorbidity | 2 | 2013 | 10588 | 0.010 |
Why?
|
Blood Platelets | 1 | 2015 | 2476 | 0.010 |
Why?
|
Colitis | 1 | 2013 | 1244 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5313 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2013 | 2324 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3541 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10478 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1837 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 2012 | 1082 | 0.010 |
Why?
|
Job Satisfaction | 1 | 2007 | 549 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17135 | 0.010 |
Why?
|
Infant | 1 | 2005 | 36510 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3785 | 0.010 |
Why?
|
Homeostasis | 1 | 2013 | 3349 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2337 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9562 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
Insurance, Health | 1 | 2011 | 2518 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14481 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14154 | 0.010 |
Why?
|
Infant, Premature | 1 | 2003 | 2124 | 0.010 |
Why?
|
Body Weight | 1 | 2003 | 4629 | 0.010 |
Why?
|
Mice | 1 | 2013 | 82017 | 0.000 |
Why?
|
Animals | 1 | 2013 | 169337 | 0.000 |
Why?
|